P-ISSN 2587-2400 | E-ISSN 2587-196X
Contact
EJMO Home
|
Toggle navigation
EJMO HOME
ABOUT JOURNAL
EDITORIAL BOARD
INSTRUCTIONS FOR AUTHORS
FOR REVIEWERS
EJMO ARCHIVE
CONTACT
EJMO Volume :
5
Issue :
1
Year :
2021
COVID-19 in EJMO
5/1
EJMO Current Issue
EJMO Archive
EJMO & Congress of Oncology and immunotherapy association
Most Cited Articles
Ahead of Print
Most Accessed Articles
Copyright Transfer Form
ICMJE COI Form
EJMO Sponsors
Amgen
Astellas
Bristol-Myers Squibb
Johnson Johnson
Merck
Pfizer
Novartis
Omnigen
Mustafa Nevzat
Arven
TEVA
Trpharm
Contact
Contact Us
Editor
Hilmi Kodaz, M.D.
Department of Medical Oncology, Acibadem Eskisehir Hospital, Eskisehir, Turkey
E-mail:
hilmikodaz@hotmail.com
,
editor@ejmo.org
,
admin@ejmo.org
Owners
On behalf of Oncology and Immunotherapy Association
President
Prof. Dr. Ismail Celik, MD
Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
E-mail:
info@immunoterapi.org
http://immunoterapi.org/
Hilmi Kodaz, M.D.
Acibadem Eskisehir Hospital, Department of Oncology; Eskisehir-Turkey
Address: Batikent Mah., Baglarbasi Sk., Starlife sitesi. 13 F No: 1, Tepebasi, Eskisehir-Turkey
E-mail:
hilmikodaz@hotmail.com
and
editor@ejmo.org
Phone: +90 507 931 42 86
Publisher
Kare Publishing
Address: Concord Istanbul, Dumlupinar Mah. Cihan Sk. No: 15 B Blok Da: 162, 34720 Kadikoy, Istanbul-Turkey
Phone: +90 216 550 61 11
Fax: +90 216 550 61 12
Web :
www.kareyayincilik.com
E-mail:
kare@kareyayincilik.com
EJMO has been indexed in web of science
( Emerging Sources Citation Index)
EJMO Citations
Number of Citations:
890
Number of Articles:
224
Accept Ratio : 31.8 %
Avg. days from submission to first decision 25.3
Avg. days from submission to final decision 26.5
EJMO NLM ID:
101720527
Our Other Journal
EJMI
Quick Search
In authors and institutes
In titles and abstracts
In keywords
In all
Copyright © 2021 Eurasian Journal of Medicine and Oncology, EJMO
EJMO & EJMO